Separate terms with OR to return results that match either term.
 
Clear All
9,752 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class (Ascending) Administration Route Package Effective Date Package Discontinuation Date Status
49349-0287-02 49349-0287 Medroxyprogesterone Acetate Medroxyprogesterone Acetate 10.0 mg/1 Hormonal Therapy Progestin Oral June 7, 2011 June 8, 2012 No Longer Used
49349-0287-08 49349-0287 Medroxyprogesterone Acetate Medroxyprogesterone Acetate 10.0 mg/1 Hormonal Therapy Progestin Oral Nov. 12, 2014 Aug. 25, 2016 No Longer Used
50090-1941-00 50090-1941 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Feb. 9, 2017 Feb. 9, 2017 No Longer Used
50090-1941-02 50090-1941 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Feb. 9, 2017 Feb. 9, 2017 No Longer Used
52125-0562-08 52125-0562 Medroxyprogesterone Acetate Medroxyprogesterone Acetate 10.0 mg/1 Hormonal Therapy Progestin Oral Feb. 28, 2013 Feb. 28, 2014 No Longer Used
52125-0803-08 52125-0803 Medroxyprogesterone Acetate Medroxyprogesterone Acetate 10.0 mg/1 Hormonal Therapy Progestin Oral Jan. 3, 2014 Jan. 3, 2015 No Longer Used
54868-0365-00 54868-0365 Estrogens, Conjugated Premarin Hormonal Therapy Estrogen Oral July 26, 1995 June 30, 2012 No Longer Used
54868-0365-01 54868-0365 Estrogens, Conjugated Premarin Hormonal Therapy Estrogen Oral July 26, 1995 July 6, 2010 No Longer Used
54868-0365-02 54868-0365 Estrogens, Conjugated Premarin Hormonal Therapy Estrogen Oral July 26, 1995 June 30, 2012 No Longer Used
54868-0365-03 54868-0365 Estrogens, Conjugated Premarin Hormonal Therapy Estrogen Oral July 26, 1995 June 30, 2012 No Longer Used
60687-0132-11 60687-0132 Exemestane Exemestane 25.0 mg/1 Hormonal Therapy Aromatase Inhibitor Oral March 31, 2015 April 30, 2017 No Longer Used
60687-0132-21 60687-0132 Exemestane Exemestane 25.0 mg/1 Hormonal Therapy Aromatase Inhibitor Oral Dec. 22, 2015 April 30, 2017 No Longer Used
62756-0093-40 62756-0093 Octreotide Acetate Octreotide Acetate 50.0 ug/mL Hormonal Therapy Somatostatin Analog Intravenous, Subcutaneous Dec. 7, 2012 Jan. 31, 2017 No Longer Used
62756-0093-44 62756-0093 Octreotide Acetate Octreotide Acetate 50.0 ug/mL Hormonal Therapy Somatostatin Analog Intravenous, Subcutaneous Aug. 31, 2012 Jan. 31, 2017 No Longer Used
62756-0094-40 62756-0094 Octreotide Acetate Octreotide Acetate 100.0 ug/mL Hormonal Therapy Somatostatin Analog Intravenous, Subcutaneous Dec. 7, 2012 Nov. 30, 2016 No Longer Used
62756-0094-44 62756-0094 Octreotide Acetate Octreotide Acetate 100.0 ug/mL Hormonal Therapy Somatostatin Analog Intravenous, Subcutaneous Aug. 31, 2012 Nov. 30, 2016 No Longer Used
62756-0095-40 62756-0095 Octreotide Acetate Octreotide Acetate 500.0 ug/mL Hormonal Therapy Somatostatin Analog Intravenous, Subcutaneous Dec. 7, 2012 Nov. 30, 2016 No Longer Used
62756-0095-44 62756-0095 Octreotide Acetate Octreotide Acetate 500.0 ug/mL Hormonal Therapy Somatostatin Analog Intravenous, Subcutaneous Aug. 31, 2012 Nov. 30, 2016 No Longer Used
68084-0448-11 68084-0448 Anastrozole Anastrozole 1.0 mg/1 Hormonal Therapy Aromatase Inhibitor Oral June 27, 2010 Jan. 31, 2017 No Longer Used
68084-0448-21 68084-0448 Anastrozole Anastrozole 1.0 mg/1 Hormonal Therapy Aromatase Inhibitor Oral June 27, 2010 Jan. 31, 2017 No Longer Used
59353-0002-10 59353-0002 Epoetin alfa-epbx RETACRIT 2000.0 [iU]/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous June 18, 2018 In Use
59353-0003-10 59353-0003 Epoetin alfa-epbx RETACRIT 3000.0 [iU]/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous June 18, 2018 In Use
59353-0004-10 59353-0004 Epoetin alfa-epbx RETACRIT 4000.0 [iU]/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous June 18, 2018 In Use
59353-0010-10 59353-0010 epoetin alfa-epbx RETACRIT 10000.0 [iU]/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous June 18, 2018 In Use
43598-0255-52 43598-0255 Zoledronic acid Zoledronic acid 4.0 mg/100mL Ancillary Therapy Bisphosphonate Intravenous Jan. 15, 2019 In Use

Found 9,752 results in 6 milliseconds — Export these results